Assessing the Effects of Tretinoin Cream on Human Skin With Optical Imaging Technologies

NCT02410980 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2022-11-01

No results posted yet for this study

Summary

The researchers will assess the effects of treatment with tretinoin cream on human skin by using non-invasive optical imaging technologies.

Conditions

  • Collagen Fibril Alteration

Interventions

DRUG

Tretinoin cream 0.1%

Assessment of the skin change

Sponsors & Collaborators

  • Unilever R&D

    collaborator INDUSTRY
  • Beckman Laser Institute University of California Irvine

    collaborator OTHER
  • University of California, Irvine

    lead OTHER

Principal Investigators

  • Mihaela Balu, PhD · Beckman Laser Institute, UCI

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02410980 on ClinicalTrials.gov